365 related articles for article (PubMed ID: 25784666)
1. Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes.
Panduru NM; Sandholm N; Forsblom C; Saraheimo M; Dahlström EH; Thorn LM; Gordin D; Tolonen N; Wadén J; Harjutsalo V; Bierhaus A; Humpert PM; Groop PH;
Diabetes Care; 2015 Jun; 38(6):1130-7. PubMed ID: 25784666
[TBL] [Abstract][Full Text] [Related]
2. Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy.
Panduru NM; Saraheimo M; Forsblom C; Thorn LM; Gordin D; Wadén J; Tolonen N; Bierhaus A; Humpert PM; Groop PH;
Diabetes Care; 2015 May; 38(5):883-90. PubMed ID: 25720601
[TBL] [Abstract][Full Text] [Related]
3. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
4. Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.
von Eynatten M; Baumann M; Heemann U; Zdunek D; Hess G; Nawroth PP; Bierhaus A; Humpert PM
Eur J Clin Invest; 2010 Feb; 40(2):95-102. PubMed ID: 19912308
[TBL] [Abstract][Full Text] [Related]
5. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.
Nielsen SE; Andersen S; Zdunek D; Hess G; Parving HH; Rossing P
Kidney Int; 2011 May; 79(10):1113-8. PubMed ID: 21270761
[TBL] [Abstract][Full Text] [Related]
6. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
7. Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors.
Conway BR; Manoharan D; Manoharan D; Jenks S; Dear JW; McLachlan S; Strachan MW; Price JF
Kidney Int; 2012 Oct; 82(7):812-8. PubMed ID: 22718188
[TBL] [Abstract][Full Text] [Related]
8. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
[TBL] [Abstract][Full Text] [Related]
9. Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease.
Gohda T; Kamei N; Koshida T; Kubota M; Tanaka K; Yamashita Y; Adachi E; Ichikawa S; Murakoshi M; Ueda S; Suzuki Y
J Diabetes Investig; 2020 Mar; 11(2):435-440. PubMed ID: 31483944
[TBL] [Abstract][Full Text] [Related]
10. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
Yamanouchi M; Skupien J; Niewczas MA; Smiles AM; Doria A; Stanton RC; Galecki AT; Duffin KL; Pullen N; Breyer MD; Bonventre JV; Warram JH; Krolewski AS
Kidney Int; 2017 Jul; 92(1):258-266. PubMed ID: 28396115
[TBL] [Abstract][Full Text] [Related]
11. Kidney injury molecule-1 correlates with kidney function in heart allograft recipients.
Przybylowski P; Malyszko J; Kozlowska S; Malyszko JS
Transplant Proc; 2011 Oct; 43(8):3061-3. PubMed ID: 21996225
[TBL] [Abstract][Full Text] [Related]
12. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients.
van Timmeren MM; Vaidya VS; van Ree RM; Oterdoom LH; de Vries AP; Gans RO; van Goor H; Stegeman CA; Bonventre JV; Bakker SJ
Transplantation; 2007 Dec; 84(12):1625-30. PubMed ID: 18165774
[TBL] [Abstract][Full Text] [Related]
13. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
[TBL] [Abstract][Full Text] [Related]
14. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
Shimizu M; Furuichi K; Toyama T; Funamoto T; Kitajima S; Hara A; Ogawa D; Koya D; Ikeda K; Koshino Y; Kurokawa Y; Abe H; Mori K; Nakayama M; Konishi Y; Samejima KI; Matsui M; Yamauchi H; Gohda T; Fukami K; Nagata D; Yamazaki H; Yuzawa Y; Suzuki Y; Fujimoto S; Maruyama S; Kato S; Naito T; Yoshimura K; Yokoyama H; Wada T;
Clin Exp Nephrol; 2018 Apr; 22(2):377-387. PubMed ID: 28889347
[TBL] [Abstract][Full Text] [Related]
15. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
[TBL] [Abstract][Full Text] [Related]
16. Kidney injury molecule-1 correlates with kidney function in renal allograft recipients.
Malyszko J; Koc-Zorawska E; Malyszko JS; Mysliwiec M
Transplant Proc; 2010 Dec; 42(10):3957-9. PubMed ID: 21168598
[TBL] [Abstract][Full Text] [Related]
17. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.
Vaidya VS; Niewczas MA; Ficociello LH; Johnson AC; Collings FB; Warram JH; Krolewski AS; Bonventre JV
Kidney Int; 2011 Feb; 79(4):464-70. PubMed ID: 20980978
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
[TBL] [Abstract][Full Text] [Related]
19. Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Schrauben SJ; Shou H; Zhang X; Anderson AH; Bonventre JV; Chen J; Coca S; Furth SL; Greenberg JH; Gutierrez OM; Ix JH; Lash JP; Parikh CR; Rebholz CM; Sabbisetti V; Sarnak MJ; Shlipak MG; Waikar SS; Kimmel PL; Vasan RS; Feldman HI; Schelling JR;
J Am Soc Nephrol; 2021 Jan; 32(1):115-126. PubMed ID: 33122288
[TBL] [Abstract][Full Text] [Related]
20. Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study.
Vélayoudom-Céphise FL; Rajaobelina K; Helmer C; Nov S; Pupier E; Blanco L; Hugo M; Farges B; Astrugue C; Gin H; Rigalleau V
Cardiovasc Diabetol; 2016 Sep; 15(1):127. PubMed ID: 27585632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]